Free Trial

Celldex Therapeutics (CLDX) Institutional Ownership

Celldex Therapeutics logo
$32.45 -0.06 (-0.18%)
Closing price 04:00 PM Eastern
Extended Trading
$33.25 +0.80 (+2.47%)
As of 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Celldex Therapeutics (NASDAQ:CLDX)

Number of
Institutional Buyers
(last 12 months)
100
Total
Institutional Inflows
(last 12 months)
$432.75M
Number of
Institutional Sellers
(last 12 months)
65
Total
Institutional Outflows
(last 12 months)
$233.20M
Get CLDX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Celldex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CLDX Institutional Buying and Selling by Quarter

Celldex Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Sei Investments Co.38,152$1.21M0.0%N/A0.049%
5/14/2026 Walleye Capital LLC8,147$258K0.0%N/A0.010%
5/13/2026Cetera Investment Advisers7,196$228K0.0%-27.3%0.009%
5/13/2026First Trust Advisors LP68,470$2.17M0.0%+78.7%0.087%
5/7/2026 Dimensional Fund Advisors LP1,059,534$33.60M0.0%+62.6%1.350%
5/7/2026 AlphaCentric Advisors LLC12,614$400K0.4%N/A0.016%
5/5/2026 Bank of New York Mellon Corp190,399$6.04M0.0%-2.1%0.286%
5/1/2026 Candriam S.C.A.278,888$8.85M0.0%N/A0.419%
4/27/2026 Simplify Asset Management Inc.68,994$2.19M0.0%-18.8%0.104%
4/27/2026 Y Intercept Hong Kong Ltd45,192$1.43M0.0%N/A0.068%
4/22/2026 Pictet Asset Management Holding SA923,696$29.30M0.0%-4.6%1.388%
4/22/2026 Sterling Capital Management LLC2,170$69K0.0%-43.0%0.003%
4/20/2026 Assenagon Asset Management S.A.146,525$4.65M0.0%N/A0.220%
4/16/2026 SG Americas Securities LLC38,008$1.21M0.0%-19.7%0.057%
4/16/2026 Diversified Trust Co7,021$223K0.0%N/A0.011%
3/9/2026Corient Private Wealth LLC234,698$6.21M0.0%-2.0%0.353%
2/19/2026 Invesco Ltd.90,144$2.45M0.0%+14.3%0.136%
2/19/2026Corient Private Wealth LLC234,328$6.21M0.0%-2.2%0.353%
2/18/2026ADAR1 Capital Management LLC646,767$17.57M1.3%+491.0%0.973%
2/18/2026XTX Topco Ltd51,523$1.40M0.0%+552.7%0.078%
2/18/2026Vestal Point Capital LP1,165,000$31.64M1.1%-3.3%1.753%
2/18/2026Virtus Investment Advisers LLC9,671$263K0.1%+72.9%0.015%
2/18/2026Wellington Management Group LLP8,079,608$219.44M0.1%+39.3%12.159%
2/18/2026SummitTX Capital L.P.43,324$1.18M0.0%-54.9%0.065%
2/18/2026Sphera Funds Management LTD.239,764$6.51M1.2%+15.4%0.361%
2/18/2026Superstring Capital Management LP88,308$2.40M1.3%N/A0.133%
2/18/2026Millennium Management LLC1,212,705$32.94M0.0%+24.4%1.825%
2/18/2026Elmind Capital LP865,000$23.49M6.9%N/A1.302%
2/18/2026Eversept Partners LP1,434,725$38.97M2.0%+24.3%2.159%
2/18/2026Commodore Capital LP2,565,000$69.67M4.6%-15.3%3.860%
2/17/2026Logos Global Management LP350,000$9.51M0.6%N/A0.527%
2/17/2026ADAR1 Capital Management LLC646,767$17.57M1.3%+491.0%0.973%
2/17/2026Braidwell LP1,858,109$50.47M1.6%+214.0%2.796%
2/17/2026Jump Financial LLC145,164$3.94M0.0%+926.4%0.218%
2/17/2026Price T Rowe Associates Inc. MD2,039,705$55.40M0.0%-14.4%3.070%
2/17/2026Rock Springs Capital Management LP692,538$18.81M1.0%-4.0%1.042%
2/17/2026California State Teachers Retirement System58,397$1.59M0.0%+5.2%0.088%
2/17/2026State of Wisconsin Investment Board38,066$1.03M0.0%-15.0%0.057%
2/17/2026Royal Bank of Canada2,292$62K0.0%-95.0%0.003%
2/17/2026Polar Capital Holdings Plc1,008,163$27.38M0.1%-22.5%1.517%
Trump is positioned. Elon lights the fuse. (Ad)

Bitcoin is back above $80,000. Altcoins are pumping. ETF inflows are accelerating. The CLARITY Act… the most bullish crypto legislation in U.S. history… is barreling toward passage. And a new Fed Chair who calls Bitcoin "the new gold" just took the helm. Every one of these catalysts is converging at the same time. That doesn't happen often. And when it does, the investors who are already positioned walk away with life-changing gains.tc pixel

See our #1 crypto for the Trump crypto bull run.
2/16/2026Panagora Asset Management Inc.21,856$594K0.0%+7.5%0.033%
2/16/2026Eventide Asset Management LLC1,642,559$44.61M0.7%-11.6%2.472%
2/16/2026Barclays PLC240,594$6.54M0.0%-1.7%0.362%
2/13/2026 Kestra Advisory Services LLC3,600$98K0.0%N/A0.005%
2/13/2026The Manufacturers Life Insurance Company 75,130$2.01M0.0%-13.7%0.113%
2/13/2026Segall Bryant & Hamill LLC514,531$13.98M0.2%-2.7%0.774%
2/13/2026Affinity Asset Advisors LLC350,000$9.51M0.5%+16.7%0.527%
2/13/2026Rafferty Asset Management LLC114,230$3.10M0.0%+17.2%0.172%
2/13/2026First Trust Advisors LP38,313$1.04M0.0%+7.8%0.058%
2/13/2026Charles Schwab Investment Management Inc.550,729$14.96M0.0%-0.6%0.829%
2/13/2026 Police & Firemen s Retirement System of New Jersey16,822$457K0.0%-7.3%0.025%
2/13/2026State Street Corp3,397,713$92.28M0.0%+19.5%5.113%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC117,589$3.19M0.0%+11.5%0.177%
2/13/2026 Wells Fargo & Company MN91,599$2.49M0.0%+35.2%0.138%
2/12/2026HRT Financial LP77,640$2.11M0.0%+21.0%0.117%
2/12/2026MetLife Investment Management LLC37,012$1.01M0.0%-5.1%0.056%
2/12/2026Renaissance Technologies LLC118,488$3.22M0.0%-39.1%0.178%
2/12/2026 Dimensional Fund Advisors LP651,716$17.70M0.0%+153.5%0.981%
2/12/2026Ensign Peak Advisors Inc6,278$171K0.0%-60.5%0.009%
2/12/2026Marex Group plc8,200$223K0.0%N/A0.012%
2/12/2026 Alps Advisors Inc.54,559$1.48M0.0%+70.9%0.082%
2/12/2026 Swiss National Bank117,900$3.20M0.0%+1.8%0.177%
2/12/2026 Nuveen LLC200,696$5.45M0.0%-19.5%0.302%
2/11/2026 Deutsche Bank AG136,485$3.71M0.0%+1.4%0.205%
2/11/2026JPMorgan Chase & Co.173,677$4.72M0.0%-6.0%0.261%
2/11/2026Propel Bio Management LLC154,300$4.19M3.6%-0.5%0.232%
2/10/2026 TD Asset Management Inc66,570$1.81M0.0%-28.0%0.100%
2/10/2026Goldman Sachs Group Inc.1,068,131$29.01M0.0%+3.8%1.607%
2/10/2026 BNP Paribas Financial Markets230,662$6.27M0.0%+72.3%0.347%
2/10/2026 SBI Okasan Asset Management Co.Ltd.16,400$427K0.0%N/A0.025%
2/10/2026 Intech Investment Management LLC33,499$910K0.0%+8.4%0.050%
2/9/2026Geode Capital Management LLC1,627,529$44.21M0.0%-1.2%2.449%
2/9/2026 Fisher Asset Management LLC937,158$25.45M0.0%+1.1%1.410%
2/6/2026 PSP Research LLC20,368$553K0.5%N/A0.031%
2/6/2026 Handelsbanken Fonder AB25,900$703K0.0%+19.9%0.039%
2/6/2026 Profund Advisors LLC42,454$1.15M0.0%+99.3%0.064%
2/6/2026 ProShare Advisors LLC11,973$325K0.0%+6.9%0.018%
2/5/2026DNB Asset Management AS16,901$459K0.0%+27.5%0.025%
1/30/2026 Values First Advisors Inc.7,728$210K0.1%N/A0.012%
1/29/2026 Pictet Asset Management Holding SA968,616$26.31M0.0%-20.1%1.458%
1/29/2026 UBS Group AG326,462$8.87M0.0%-21.6%0.491%
1/29/2026Vanguard Group Inc.4,027,407$109.38M0.0%+1.8%6.061%
1/28/2026 Arizona State Retirement System16,524$449K0.0%-6.4%0.025%
1/28/2026 Universal Beteiligungs und Servicegesellschaft mbH32,263$876K0.0%+67.2%0.049%
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank25,317$688K0.0%+11.0%0.038%
1/21/2026 TSP Capital Management Group LLC375,127$10.19M2.5%-0.2%0.565%
1/15/2026 Nisa Investment Advisors LLC905$25K0.0%-35.1%0.001%
1/14/2026Hennion & Walsh Asset Management Inc.46,965$1.28M0.0%+31.2%0.071%
1/14/2026 Mirador Capital Partners LP170,659$4.64M0.6%+2.9%0.257%
1/9/2026 Overbrook Management Corp11,537$313K0.1%+31.1%0.017%
Read this or regret it forever (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
1/9/2026 SG Americas Securities LLC47,340$1.29M0.0%+143.2%0.071%
1/1/2026JPMorgan Chase & Co.184,775$4.78M0.0%-21.0%0.278%
1/1/2026Tudor Investment Corp ET AL31,618$818K0.0%N/A0.048%
12/9/2025Tudor Investment Corp ET AL31,618$818K0.0%N/A0.048%
11/20/2025 Wilmington Savings Fund Society FSB1,633$42K0.0%N/A0.002%
11/18/2025Advisory Services Network LLC5,390$139K0.0%N/A0.008%
11/17/2025Woodline Partners LP199,291$5.16M0.0%-86.7%0.300%
11/17/2025Verition Fund Management LLC55,140$1.43M0.0%+62.8%0.083%
11/17/2025Vestal Point Capital LP1,205,000$31.17M1.4%-31.1%1.813%
11/17/2025Polar Capital Holdings Plc1,300,436$33.64M0.2%+5.9%1.957%


CLDX Institutional Ownership - Frequently Asked Questions

During the previous two years, 184 institutional investors and hedge funds held shares of Celldex Therapeutics. The most heavily invested institutionals were Wellington Management Group LLP ($219.44M), FMR LLC ($122.75M), Kynam Capital Management LP ($121.71M), Vanguard Group Inc. ($109.38M), State Street Corp ($92.28M), Bellevue Group AG ($92.04M), and Commodore Capital LP ($69.67M).Learn more on Celldex Therapeutics' institutional investors.

Of the 159 institutional investors that purchased Celldex Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wellington Management Group LLP ($4.01M), Price T Rowe Associates Inc. MD ($3.34M), Braidwell LP ($1.86M), Vestal Point Capital LP ($1.86M), Deep Track Capital LP ($1.54M), Point72 Asset Management L.P. ($1.50M), and ADAR1 Capital Management LLC ($1.14M).

Institutional investors have bought a total of 17,078,228 shares in the last 24 months. This purchase volume represents approximately $432.75M in transactions.

Of the 63 institutional investors that sold Celldex Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Eventide Asset Management LLC ($2.62M), Woodline Partners LP ($2.13M), Commodore Capital LP ($885K), Vestal Point Capital LP ($691.35K), UBS Group AG ($514.78K), Goldman Sachs Group Inc. ($481.25K), and Price T Rowe Associates Inc. MD ($342.81K).

Institutional investors have sold a total of 9,958,902 shares in the last 24 months. This volume of shares sold represents approximately $233.20M in transactions.



This page (NASDAQ:CLDX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners